Skip to main content

Find Clinical Trials

Home
Conditions
Chromosome 2q32-Q33 Deletion Syndrome

Clinical trial condition

Chromosome 2q32-Q33 Deletion Syndrome

Explore clinical trials studying Chromosome 2q32-Q33 Deletion Syndrome. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Chromosome 2q32-Q33 Deletion Syndrome trial results

Active, Not Recruiting

Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

NCT06192758

Conditions: Cancer, Chromosome 2q32-Q33 Deletion Syndrome, Neoplasms, +1 more
Locations: Northwestern Memorial Hospital Chicago, Illinois, United States

View Trial Details